Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey

Authors: Fernando MA Giuffrida, Alexis D Guedes, Eloa R Rocco, Denise B Mory, Patricia Dualib, Odelisa S Matos, Reine M Chaves-Fonseca, Roberta A Cobas, Carlos Antonio Negrato, Marilia B Gomes, Sergio A Dib, Brazilian Type 1 Diabetes Study Group (BrazDiab1SG)

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Cardiovascular risk factors (CVRF) may cluster in type 1 diabetes, analogously to the metabolic syndrome described in type 2 diabetes. The threshold of HbA1c above which lipid variables start changing behavior is unclear. This study aims to 1) assess the behavior of dyslipidemia according to HbA1c values; 2) detect a threshold of HbA1c beyond which lipids start to change and 3) compare the clustering of lipids and other non-lipid CVRF among strata of HbA1c individuals with type 1 diabetes.

Methods

Effects of HbA1c quintiles (1st: ≤7.4%; 2nd: 7.5-8.5%; 3rd: 8.6-9.6%; 4th: 9.7-11.3%; and 5th: >11.5%) and covariates (gender, BMI, blood pressure, insulin daily dose, lipids, statin use, diabetes duration) on dyslipidemia were studied in 1275 individuals from the Brazilian multi-centre type 1 diabetes study and 171 normal controls.

Results

Body size and blood pressure were not correlated to lipids and glycemic control. OR (99% CI) for high-LDL were 2.07 (1.21-3.54) and 2.51 (1.46-4.31), in the 4th and 5th HbA1c quintiles, respectively. Hypertriglyceridemia increased in the 5th quintile of HbA1c, OR 2.76 (1.20-6.37). OR of low-HDL-cholesterol were 0.48 (0.24-0.98) and 0.41 (0.19-0.85) in the 3rd and 4th HbA1c quintiles, respectively. HDL-cholesterol correlated positively (0.437) with HbA1c in the 3rd quintile. HDL-cholesterol and insulin dose correlated inversely in all levels of glycemic control.

Conclusions

Correlation of serum lipids with HbA1c is heterogeneous across the spectrum of glycemic control in type 1 diabetes individuals. LDL-cholesterol and triglycerides worsened alongside HbA1c with distinct thresholds. Association of lower HDL-cholesterol with higher daily insulin dose is consistent and it points out to a role of exogenous hyperinsulinemia in the pathophysiology of the CVRF clustering. These data suggest diverse pathophysiological processes depending on HbA1c, refuting a unified explanation for cardiovascular risk in type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Margeirsdottir HD, Larsen JR, Brunborg C, Øverby NC, Dahl-Jørgensen K, Norwegian Study Group for Childhood Diabetes: High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia. 2008, 51: 554-561. 10.1007/s00125-007-0921-8.CrossRefPubMed Margeirsdottir HD, Larsen JR, Brunborg C, Øverby NC, Dahl-Jørgensen K, Norwegian Study Group for Childhood Diabetes: High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia. 2008, 51: 554-561. 10.1007/s00125-007-0921-8.CrossRefPubMed
2.
go back to reference American Diabetes Association: Executive summary: Standards of medical care in diabetes--2012. Diabetes Care. 2012, 35 (1): S4-S10.CrossRef American Diabetes Association: Executive summary: Standards of medical care in diabetes--2012. Diabetes Care. 2012, 35 (1): S4-S10.CrossRef
3.
go back to reference Leosdottir M, Willenheimer R, Persson M, Nilsson PM: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö Preventive Project. Cardiovasc Diabetol. 2011, 10: 118-10.1186/1475-2840-10-118.PubMedCentralCrossRefPubMed Leosdottir M, Willenheimer R, Persson M, Nilsson PM: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö Preventive Project. Cardiovasc Diabetol. 2011, 10: 118-10.1186/1475-2840-10-118.PubMedCentralCrossRefPubMed
4.
go back to reference Schwab KO, Doerfer J, Naeke A, Rohrer T, Wiemann D, Marg W, Hofer SE, Holl RW: German/Austrian Pediatric DPV Initiative: Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes–reference data from the German diabetes documentation and quality management system (DPV). Pediatr Diabetes. 2009, 10: 184-192. 10.1111/j.1399-5448.2008.00469.x.CrossRefPubMed Schwab KO, Doerfer J, Naeke A, Rohrer T, Wiemann D, Marg W, Hofer SE, Holl RW: German/Austrian Pediatric DPV Initiative: Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes–reference data from the German diabetes documentation and quality management system (DPV). Pediatr Diabetes. 2009, 10: 184-192. 10.1111/j.1399-5448.2008.00469.x.CrossRefPubMed
5.
go back to reference Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M: Coronary Artery Calcification in Type 1 Diabetes Study: Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003, 52: 2833-2839. 10.2337/diabetes.52.11.2833.CrossRefPubMed Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M: Coronary Artery Calcification in Type 1 Diabetes Study: Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003, 52: 2833-2839. 10.2337/diabetes.52.11.2833.CrossRefPubMed
6.
go back to reference Costacou T, Evans RW, Orchard TJ: High-density lipoprotein cholesterol in diabetes: is higher always better?. J Clin Lipidol. 2011, 5: 387-394. 10.1016/j.jacl.2011.06.011.PubMedCentralCrossRefPubMed Costacou T, Evans RW, Orchard TJ: High-density lipoprotein cholesterol in diabetes: is higher always better?. J Clin Lipidol. 2011, 5: 387-394. 10.1016/j.jacl.2011.06.011.PubMedCentralCrossRefPubMed
7.
go back to reference Wong ND, Glovaci D, Wong K, Malik S, Franklin SS, Wygant G, Iloeje U: Global cardiovascular disease risk assessment in United States adults with diabetes. Diab Vasc Dis Res. 2012, 9: 146-152. 10.1177/1479164112436403.CrossRefPubMed Wong ND, Glovaci D, Wong K, Malik S, Franklin SS, Wygant G, Iloeje U: Global cardiovascular disease risk assessment in United States adults with diabetes. Diab Vasc Dis Res. 2012, 9: 146-152. 10.1177/1479164112436403.CrossRefPubMed
8.
go back to reference Dalla Pozza R, Beyerlein A, Thilmany C, Weissenbacher C, Netz H, Schmidt H, Bechtold S: The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol. 2011, 10: 53-10.1186/1475-2840-10-53.PubMedCentralCrossRefPubMed Dalla Pozza R, Beyerlein A, Thilmany C, Weissenbacher C, Netz H, Schmidt H, Bechtold S: The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol. 2011, 10: 53-10.1186/1475-2840-10-53.PubMedCentralCrossRefPubMed
9.
go back to reference Anderson SG, Narayanan RP, Amlesh J, Qureshi MZ, Heald AH: Type 1 diabetes in Cheshire: cardiometabolic risk factor trends (2004–2009). Prim Care Diabetes. 2012, 6: 123-126. 10.1016/j.pcd.2011.10.007.CrossRefPubMed Anderson SG, Narayanan RP, Amlesh J, Qureshi MZ, Heald AH: Type 1 diabetes in Cheshire: cardiometabolic risk factor trends (2004–2009). Prim Care Diabetes. 2012, 6: 123-126. 10.1016/j.pcd.2011.10.007.CrossRefPubMed
10.
go back to reference van Vliet M, Van der Heyden JC, Diamant M, Rosenstiel Von IA, Schindhelm RK, Heymans MW, Brandjes DPM, Beijnen JH, Aanstoot HJ, Veeze HJ: Overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children. Eur J Pediatr. 2011, 171: 493-498.PubMedCentralCrossRefPubMed van Vliet M, Van der Heyden JC, Diamant M, Rosenstiel Von IA, Schindhelm RK, Heymans MW, Brandjes DPM, Beijnen JH, Aanstoot HJ, Veeze HJ: Overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children. Eur J Pediatr. 2011, 171: 493-498.PubMedCentralCrossRefPubMed
11.
go back to reference Guy J, Ogden L, Wadwa RP, Hamman RF, Mayer-Davis EJ, Liese AD, D'Agostino RB, Marcovina S, Dabelea D: Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case–control study. Diabetes Care. 2009, 32: 416-420. 10.2337/dc08-1775.PubMedCentralCrossRefPubMed Guy J, Ogden L, Wadwa RP, Hamman RF, Mayer-Davis EJ, Liese AD, D'Agostino RB, Marcovina S, Dabelea D: Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case–control study. Diabetes Care. 2009, 32: 416-420. 10.2337/dc08-1775.PubMedCentralCrossRefPubMed
12.
go back to reference Kilpatrick ES, Rigby AS, Atkin SL: Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care. 2007, 30: 707-712. 10.2337/dc06-1982.CrossRefPubMed Kilpatrick ES, Rigby AS, Atkin SL: Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care. 2007, 30: 707-712. 10.2337/dc06-1982.CrossRefPubMed
13.
go back to reference Valerio G, Iafusco D, Zucchini S, Maffeis C: Study-Group on Diabetes of Italian Society of Pediatric Endocrinology and Diabetology (ISPED): Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2012, 97: 99-104. 10.1016/j.diabres.2012.01.022.CrossRefPubMed Valerio G, Iafusco D, Zucchini S, Maffeis C: Study-Group on Diabetes of Italian Society of Pediatric Endocrinology and Diabetology (ISPED): Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2012, 97: 99-104. 10.1016/j.diabres.2012.01.022.CrossRefPubMed
14.
go back to reference Reaven GM: The metabolic syndrome: time to get off the merry-go-round?. J Intern Med. 2011, 269: 127-136. 10.1111/j.1365-2796.2010.02325.x.CrossRefPubMed Reaven GM: The metabolic syndrome: time to get off the merry-go-round?. J Intern Med. 2011, 269: 127-136. 10.1111/j.1365-2796.2010.02325.x.CrossRefPubMed
15.
go back to reference Defronzo RA: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009, 58: 773-795. 10.2337/db09-9028.PubMedCentralCrossRefPubMed Defronzo RA: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009, 58: 773-795. 10.2337/db09-9028.PubMedCentralCrossRefPubMed
16.
go back to reference Lawlor DA, Ebrahim S, May M, Davey Smith G: (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004, 159: 1013-1018. 10.1093/aje/kwh150.CrossRefPubMed Lawlor DA, Ebrahim S, May M, Davey Smith G: (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004, 159: 1013-1018. 10.1093/aje/kwh150.CrossRefPubMed
17.
go back to reference Woolston A, Tu Y-K, Baxter PD, Gilthorpe MS: A Comparison of Different Approaches to Unravel the Latent Structure within Metabolic Syndrome. PLoS One. 2012, 7: e34410-10.1371/journal.pone.0034410.PubMedCentralCrossRefPubMed Woolston A, Tu Y-K, Baxter PD, Gilthorpe MS: A Comparison of Different Approaches to Unravel the Latent Structure within Metabolic Syndrome. PLoS One. 2012, 7: e34410-10.1371/journal.pone.0034410.PubMedCentralCrossRefPubMed
18.
go back to reference Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, Falces C, Serrano-Rios M, Gabriel R, Shaw JE, Zimmet PZ, Haffner S: A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006, 29: 113-122. 10.2337/diacare.29.01.06.dc05-0862.CrossRefPubMed Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, Falces C, Serrano-Rios M, Gabriel R, Shaw JE, Zimmet PZ, Haffner S: A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006, 29: 113-122. 10.2337/diacare.29.01.06.dc05-0862.CrossRefPubMed
19.
go back to reference Li C, Ford ES: Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007, 30: 1556-1561. 10.2337/dc06-2481.CrossRefPubMed Li C, Ford ES: Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007, 30: 1556-1561. 10.2337/dc06-2481.CrossRefPubMed
20.
go back to reference Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B: Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord. 2001, 25: 1782-1788. 10.1038/sj.ijo.0801837.CrossRefPubMed Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B: Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord. 2001, 25: 1782-1788. 10.1038/sj.ijo.0801837.CrossRefPubMed
21.
go back to reference Shen B-J, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A, Ward KD: Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol. 2003, 157: 701-711. 10.1093/aje/kwg045.CrossRefPubMed Shen B-J, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A, Ward KD: Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol. 2003, 157: 701-711. 10.1093/aje/kwg045.CrossRefPubMed
22.
go back to reference Wang J-J, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J: The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose. Diabetes Care. 2004, 27: 2429-2437. 10.2337/diacare.27.10.2429.CrossRefPubMed Wang J-J, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J: The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose. Diabetes Care. 2004, 27: 2429-2437. 10.2337/diacare.27.10.2429.CrossRefPubMed
23.
go back to reference Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D, SEARCH for Diabetes in Youth Study Group: Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2008, 7: 89-95.CrossRef Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D, SEARCH for Diabetes in Youth Study Group: Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2008, 7: 89-95.CrossRef
24.
go back to reference Giuffrida FMA, Sallum CFC, Gabbay MAL, Gomes MB, Pires AC, Dib SA: Relationship between glycated hemoglobin and metabolic syndrome of type 1 and type 2 diabetes: a factor analysis study. Diabetes Care. 2010, 33: e80-10.2337/dc09-2280.CrossRefPubMed Giuffrida FMA, Sallum CFC, Gabbay MAL, Gomes MB, Pires AC, Dib SA: Relationship between glycated hemoglobin and metabolic syndrome of type 1 and type 2 diabetes: a factor analysis study. Diabetes Care. 2010, 33: e80-10.2337/dc09-2280.CrossRefPubMed
25.
go back to reference van Vliet M, Heymans MW, Rosenstiel Von IA, Brandjes DPM, Beijnen JH, Diamant M: Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol. 2011, 10: 106-10.1186/1475-2840-10-106.PubMedCentralCrossRefPubMed van Vliet M, Heymans MW, Rosenstiel Von IA, Brandjes DPM, Beijnen JH, Diamant M: Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol. 2011, 10: 106-10.1186/1475-2840-10-106.PubMedCentralCrossRefPubMed
26.
go back to reference Gomes MB, Coral M, Cobas RA, Dib SA, Canani LH, Nery M, de Freitas MCF, Faria M, Felício JS, da Silva SC, Pedrosa H, Costa E, Forti A, Rea RR, Pires AC, Montenegro Junior R, Oliveira JE, Rassi N, Negrato CA: Prevalence of adults with type 1 diabetes who meet the goals of care in daily clinical practice: a nationwide multicenter study in Brazil. Diabetes Res Clin Pract. 2012, 97: 63-70. 10.1016/j.diabres.2012.02.008.CrossRefPubMed Gomes MB, Coral M, Cobas RA, Dib SA, Canani LH, Nery M, de Freitas MCF, Faria M, Felício JS, da Silva SC, Pedrosa H, Costa E, Forti A, Rea RR, Pires AC, Montenegro Junior R, Oliveira JE, Rassi N, Negrato CA: Prevalence of adults with type 1 diabetes who meet the goals of care in daily clinical practice: a nationwide multicenter study in Brazil. Diabetes Res Clin Pract. 2012, 97: 63-70. 10.1016/j.diabres.2012.02.008.CrossRefPubMed
27.
go back to reference National Cholesterol Education Program (NCEP) Expert Panel on Detection: Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection: Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421.
28.
go back to reference Rocco ER, Mory DB, Bergamin CS, Valente F, Miranda VL, Calegare BFA, Silva RQ, Dib SA: Optimal cutoff points for body mass index, waist circumference and HOMA-IR to identify a cluster of cardiometabolic abnormalities in normal glucose-tolerant Brazilian children and adolescents. Arq Bras Endocrinol Metabol. 2011, 55: 638-645. 10.1590/S0004-27302011000800020.CrossRefPubMed Rocco ER, Mory DB, Bergamin CS, Valente F, Miranda VL, Calegare BFA, Silva RQ, Dib SA: Optimal cutoff points for body mass index, waist circumference and HOMA-IR to identify a cluster of cardiometabolic abnormalities in normal glucose-tolerant Brazilian children and adolescents. Arq Bras Endocrinol Metabol. 2011, 55: 638-645. 10.1590/S0004-27302011000800020.CrossRefPubMed
29.
go back to reference Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH: EURODIAB IDDM Complications Study Group: Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med. 2001, 18: 786-796. 10.1046/j.0742-3071.2001.00571.x.CrossRefPubMed Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH: EURODIAB IDDM Complications Study Group: Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med. 2001, 18: 786-796. 10.1046/j.0742-3071.2001.00571.x.CrossRefPubMed
30.
go back to reference Maahs DM, Hokanson JE, Wang H, Kinney GL, Snell-Bergeon JK, East A, Bergman BC, Schauer IE, Rewers M, Eckel RH: Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes. 2010, 59: 1771-1779. 10.2337/db09-1626.PubMedCentralCrossRefPubMed Maahs DM, Hokanson JE, Wang H, Kinney GL, Snell-Bergeon JK, East A, Bergman BC, Schauer IE, Rewers M, Eckel RH: Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes. 2010, 59: 1771-1779. 10.2337/db09-1626.PubMedCentralCrossRefPubMed
31.
go back to reference Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten C-GA, Taskinen M-R, Groop P-H, FinnDiane Study Group: Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care. 2005, 28: 2019-2024. 10.2337/diacare.28.8.2019.CrossRefPubMed Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten C-GA, Taskinen M-R, Groop P-H, FinnDiane Study Group: Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care. 2005, 28: 2019-2024. 10.2337/diacare.28.8.2019.CrossRefPubMed
32.
go back to reference Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, Eckel RH, Perreault L, Rewers M: Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab. 2012, 97: 1663-1672. 10.1210/jc.2011-3172.PubMedCentralCrossRefPubMed Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, Eckel RH, Perreault L, Rewers M: Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab. 2012, 97: 1663-1672. 10.1210/jc.2011-3172.PubMedCentralCrossRefPubMed
33.
go back to reference Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M: Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care. 2005, 28: 1051-1056. 10.2337/diacare.28.5.1051.CrossRefPubMed Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M: Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care. 2005, 28: 1051-1056. 10.2337/diacare.28.5.1051.CrossRefPubMed
35.
go back to reference Cleland SJ: Cardiovascular risk in double diabetes mellitus–when two worlds collide. Nat Publ Group. 2012, 8: 476-485. Cleland SJ: Cardiovascular risk in double diabetes mellitus–when two worlds collide. Nat Publ Group. 2012, 8: 476-485.
36.
go back to reference Kline P: An Easy Guide to Factor Analysis. 1993, East Sussex: Routledge, 1st Kline P: An Easy Guide to Factor Analysis. 1993, East Sussex: Routledge, 1st
Metadata
Title
Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey
Authors
Fernando MA Giuffrida
Alexis D Guedes
Eloa R Rocco
Denise B Mory
Patricia Dualib
Odelisa S Matos
Reine M Chaves-Fonseca
Roberta A Cobas
Carlos Antonio Negrato
Marilia B Gomes
Sergio A Dib
Brazilian Type 1 Diabetes Study Group (BrazDiab1SG)
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-156

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue